Login / Signup

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.

Yu-Ling YuJustyna SiwyDe-Wei AnArantxa GonzálezTine HansenAgnieszka LatosinskaPierpaolo PellicoriSusana RavassaBeatrice MariottoniJob A J VerdonschotFozia AhmedJohannes PetutschniggPatrick RossignolStephane HeymansJoe J CuthbertNicolas GirerdAndrew L ClarkPeter VerhammeTim S NawrotStefan JanssensJohn G F ClelandFaiez ZannadJavier DiezHarald MischakJoao Pedro FerreiraJan A Staessennull null
Published in: Heart (British Cardiac Society) (2024)
NCT02556450.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • label free
  • randomized controlled trial
  • open label
  • binding protein